These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2570972)

  • 21. Surrogate markers for AIDS treatment.
    Jacobson M
    Nurs Times; 1991 May 29-Jun 4; 87(22):49. PubMed ID: 1675013
    [No Abstract]   [Full Text] [Related]  

  • 22. [Another AIDS drug. Azidothymidine--dideoxycytidine].
    Moosmann EB
    Fortschr Med; 1992 Jun; 110(18):28-30. PubMed ID: 1353746
    [No Abstract]   [Full Text] [Related]  

  • 23. CD4 counts as surrogate markers for progression to AIDS.
    Hirschel B
    Ann Intern Med; 1994 Jan; 120(1):87; author reply 88. PubMed ID: 7902687
    [No Abstract]   [Full Text] [Related]  

  • 24. CD4 counts as surrogate markers for progression to AIDS.
    Harris PJ
    Ann Intern Med; 1994 Jan; 120(1):88. PubMed ID: 7902690
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of the HIV-infected patient.
    Bryan CS; Postic B
    J S C Med Assoc; 1988 Sep; 84(9):437-43. PubMed ID: 2903271
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative study of various biological markers in HIV 1 infection].
    Serra JE; Pombo V; Côrte-Real R; da Cunha S; Meliço-Silvestre A
    Acta Med Port; 1993 Jan; 6(1):5-9. PubMed ID: 8097351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concorde trial of immediate versus deferred zidovudine.
    Graham NM
    Lancet; 1994 May; 343(8909):1355-6; author reply 1358. PubMed ID: 7910336
    [No Abstract]   [Full Text] [Related]  

  • 28. Surrogate end points in clinical trials.
    Ellenberg SS
    BMJ; 1991 Jan; 302(6768):63-4. PubMed ID: 1671650
    [No Abstract]   [Full Text] [Related]  

  • 29. Bleak news from the AIDS front.
    Berger PB
    CMAJ; 1993 Oct; 149(7):1016-8. PubMed ID: 8104677
    [No Abstract]   [Full Text] [Related]  

  • 30. Lymphocytes' intrinsic lymphoproliferative capacity in patients with AIDS treated with zidovudine.
    Gerding MN; Schuurman HJ; Bast BJ; Borleffs JC
    AIDS; 1989 Oct; 3(10):671-3. PubMed ID: 2574585
    [No Abstract]   [Full Text] [Related]  

  • 31. The value of the CD4+ count of 500 cells/microliters.
    Volberding P
    Drugs; 1995; 49 Suppl 1():4-8; discussion 38-40. PubMed ID: 7614901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New, in Austria registered specialty drugs. Hivid (2',3'-dideoxycytidine; ddC)].
    Töglhofer W
    Wien Klin Wochenschr; 1992; 104(12):363-7. PubMed ID: 1353278
    [No Abstract]   [Full Text] [Related]  

  • 33. Didanosine therapy in patients intolerant of or failing zidovudine therapy.
    Rathbun RC; Martin ES
    Ann Pharmacother; 1992 Nov; 26(11):1347-51. PubMed ID: 1362093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
    Fischl MA; Parker CB; Pettinelli C; Wulfsohn M; Hirsch MS; Collier AC; Antoniskis D; Ho M; Richman DD; Fuchs E
    N Engl J Med; 1990 Oct; 323(15):1009-14. PubMed ID: 1977079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uses of CD4-lymphocyte count in AIDS treatment decisions.
    De Gruttola V; Gelman R; Lagakos S
    Infect Agents Dis; 1993 Oct; 2(5):304-13. PubMed ID: 7909710
    [No Abstract]   [Full Text] [Related]  

  • 36. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee.
    Lancet; 1994 Apr; 343(8902):871-81. PubMed ID: 7908356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug cuts fetal HIV infection.
    Klitsch M
    Fam Plann Perspect; 1994; 26(3):98. PubMed ID: 8070553
    [No Abstract]   [Full Text] [Related]  

  • 38. After Concorde.
    Gazzard BG
    BMJ; 1993 Apr; 306(6884):1016-7. PubMed ID: 8098237
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.
    Volberding PA; Lagakos SW; Grimes JM; Stein DS; Rooney J; Meng TC; Fischl MA; Collier AC; Phair JP; Hirsch MS
    N Engl J Med; 1995 Aug; 333(7):401-7. PubMed ID: 7616988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early treatment with zidovudine; a turning point in the campaign against AIDS?].
    Lange JM; Goudsmit J
    Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2599-601. PubMed ID: 2691897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.